Agile Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Agile Therapeutics develops and commercializes prescription contraceptive products for women. Read more

Alfred Altomari's photo - Chairman & CEO of Agile Therapeutics

Chairman & CEO

Alfred Altomari

CEO Approval Rating

88/100

Founded:

1997

Status:

PublicNASDAQAGRX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Lupin is the top competitor of Agile Therapeutics. Lupin is headquartered in Baltimore, Maryland, and was founded in 2003. Lupin competes in the Pharmaceuticals field. Lupin generates 18,711% the revenue of Agile Therapeutics.

Amneal is perceived as one of Agile Therapeutics's biggest rivals. Amneal was founded in Bridgewater, New Jersey} in 2002. Like Agile Therapeutics, Amneal also operates in the Pharmaceuticals industry. Compared to Agile Therapeutics, Amneal generates $1.7B more revenue.

TherapeuticsMD is seen as one of Agile Therapeutics's top competitors. TherapeuticsMD is a Public company that was founded in Boca Raton, Florida in 2008. Like Agile Therapeutics, TherapeuticsMD also works within the Pharmaceuticals industry. TherapeuticsMD has 335 more employees vs. Agile Therapeutics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is XBiotech a competitor of Agile Therapeutics?

Quarterly and Annual Revenue

Coming soon for Agile Therapeutics!

Annual Revenue

$10.7M

Agile Therapeutics's revenue is the ranked 18th among it's top 10 competitors. The top 10 competitors average 14.8B.

Acquisitions

No recent acquisitions found related to Agile Therapeutics

Agile Therapeutics Funding History

$2M$48M$71.7M$129.7M$149.7M$157.5M$192.5M

Since Agile Therapeutics was founded in 1997, it has participated in 10 rounds of funding. In total Agile Therapeutics has raised $192.5M. Agile Therapeutics' last funding round was on Feb 2020 for a total of $35.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Feb 2020
$35M

Perceptive Advisors

Equity
Mar 2019
$7.8M
-
Equity
Jan 2015
$20M
-
IPO
May 2014
$55M

Debt
Apr 2014
$3M

Total Funding: $192.5M

Since Agile Therapeutics was founded in 1997, it has participated in 10 rounds of funding. In total Agile Therapeutics has raised $192.5M. Agile Therapeutics' last funding round was on Feb 2020 for a total of $35.0M

Investments

No recent investments found related to Agile Therapeutics

Agile Therapeutics News

September 2, 2020MarketScreener

Agile Therapeutics Launches I'm So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control

(marketscreener.com) Visit BirthControlDoneMyWay.com to learn more about some of the many available c... See more »
August 11, 2020Benzinga

Agile Therapeutics to Participate in Maxim Group's Leading Innovators in Women's Health Virtual Conference

PRINCETON, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (NASDAQ:AGRX), a women's ... See more »
May 5, 2020Proactive Investors

Agile ended 1Q 2020 with nearly $94M in cash as it prepares to commercialize Twirla contraceptive

CEO Al Altomari called quarter that ended March 31 'transformational' as the FDA approved its flagshi... See more »
April 22, 2020Proactive Investors

Agile Therapeutics to add pharmaceutical executive, Yale professor to its board of directors

Sharon Barbari and Sandra Carson are expected to join the board after the company's annual meeting of... See more »
March 23, 2020Proactive Investors

Agile Therapeutics preps for commercialization of contraceptive skin patch Twirla

Twirla, which earned FDA approval in early 2020, is worn weekly and delivers daily doses of estrogen ... See more »

Agile Therapeutics Press Releases

August 8, 2019GlobalNewswire

Agile Therapeutics Announces Full Exercise of Over-Allotment Option by Underwriters

PRINCETON, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's... See more »
May 2, 2019GlobeNewswire

Agile Therapeutics Reports First Quarter 2019 Financial Results

Company Plans to Resubmit Twirla® NDA in Second Quarter of 2019... See more »
March 28, 2019GlobeNewswire

Agile Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference in London, UK

PRINCETON, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women'... See more »
March 15, 2019GlobeNewswire

Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress

PRINCETON, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women... See more »
January 10, 2019StreetInsider

Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance

Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on Janua... See more »
January 10, 2019StreetInsider

Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance

Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on Janua... See more »

Headquarters

101 Poor Farm Road , NJ

Princeton, New Jersey08540

609-683-1880

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Agile Therapeutics develops and commercializes prescription contraceptive products for women. Agile Therapeutics was founded in 1997. Agile Therapeutics' headquarters is located in Princeton, New Jersey, USA 08540. It has raised 192.5M in 10 rounds. T...

CEO

Agile Therapeutics's Chairman & CEO, Alfred Altomari, currently has an approval rating of 88%. Agile Therapeutics's primary competitors are Lupin, Amneal & TherapeuticsMD.

Website

agiletherapeutics.com

Frequently Asked Questions about Agile Therapeutics

  1. When was Agile Therapeutics founded?

    Agile Therapeutics was founded in 1997
  2. Who is Agile Therapeutics's CEO?

    Agile Therapeutics's CEO is Alfred Altomari
  3. How much revenue does Agile Therapeutics generate?

    Agile Therapeutics generates $10.7M in revenue
  4. How much funding does Agile Therapeutics have?

    Agile Therapeutics has historically raised $192.5M in funding
  1. Where is Agile Therapeutics's headquarters?

    Agile Therapeutics's headquarters is in Princeton New Jersey, USA
  2. How many employees does Agile Therapeutics have?

    Agile Therapeutics has 13 employees
  3. What sector does Agile Therapeutics operate in?

    Agile Therapeutics is in Pharmaceuticals
  4. Who are Agile Therapeutics's competitors?

    Agile Therapeutics's top competitors are Lupin, Amneal, TherapeuticsMD